Ontology highlight
ABSTRACT: Background
Medical cannabinoids are controversial. Their use is comparatively rare, but it is rising. Since 2017, cannabinoids can be prescribed in Germany for a broader range of indications. Patient surveys on these drugs are hampered by the stigmatization of cannabinoids and their (still) low prevalence in medical contexts. Against this background, patients' willingness to provide information is limited. Moreover, it is logistically challenging to reach them with a survey. A thorough knowledge of currently ongoing therapies and their effects and side effects, however, is important for a more appropriate and effective use of cannabinoids in the future.Objective
This study is an exploratory data collection using a representative sample. The main goal is to provide a detaile
SUBMITTER: Fischer JM
PROVIDER: S-EPMC10131879 | biostudies-literature | 2023 Mar
REPOSITORIES: biostudies-literature